[go: up one dir, main page]

GB0111597D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB0111597D0
GB0111597D0 GBGB0111597.1A GB0111597A GB0111597D0 GB 0111597 D0 GB0111597 D0 GB 0111597D0 GB 0111597 A GB0111597 A GB 0111597A GB 0111597 D0 GB0111597 D0 GB 0111597D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0111597.1A
Other versions
GB2377633A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Pharma Ltd
Original Assignee
GW Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Pharmaceuticals Ltd filed Critical GW Pharmaceuticals Ltd
Priority to GB0111597A priority Critical patent/GB2377633A/en
Publication of GB0111597D0 publication Critical patent/GB0111597D0/en
Priority to EP10180628.9A priority patent/EP2292211A3/en
Priority to CA002438097A priority patent/CA2438097C/en
Priority to GB0319041A priority patent/GB2388543A/en
Priority to DK02712063.3T priority patent/DK1361864T3/en
Priority to EP10180638A priority patent/EP2298283A3/en
Priority to EP10180665.1A priority patent/EP2298284A3/en
Priority to CA2533400A priority patent/CA2533400C/en
Priority to PT2712063T priority patent/PT1361864E/en
Priority to CZ2003-2458A priority patent/CZ306277B6/en
Priority to CN02808220.6A priority patent/CN1886117B/en
Priority to PCT/GB2002/000620 priority patent/WO2002064109A2/en
Priority to EP02712063.3A priority patent/EP1361864B9/en
Priority to US10/468,041 priority patent/US10004684B2/en
Priority to KR1020037010780A priority patent/KR100886668B1/en
Priority to GB0203527A priority patent/GB2380129B/en
Priority to MXPA03007215A priority patent/MXPA03007215A/en
Priority to HU0303182A priority patent/HU227452B1/en
Priority to ES02712063.3T priority patent/ES2444641T3/en
Priority to EP10180611.5A priority patent/EP2286793A3/en
Priority to IL15713002A priority patent/IL157130A0/en
Priority to NZ527289A priority patent/NZ527289A/en
Priority to DE10296335T priority patent/DE10296335T5/en
Priority to JP2002563905A priority patent/JP4467883B2/en
Priority to SI200231042T priority patent/SI1361864T1/en
Priority to PL364177A priority patent/PL216740B1/en
Priority to HK03108883.0A priority patent/HK1056509B/en
Priority to AU2002231970A priority patent/AU2002231970B2/en
Priority to TW91102626A priority patent/TWI222882B/en
Publication of GB2377633A publication Critical patent/GB2377633A/en
Priority to ZA2003/06074A priority patent/ZA200306074B/en
Priority to NO20033556A priority patent/NO334743B1/en
Priority to CY20141100157T priority patent/CY1115072T1/en
Priority to US15/586,478 priority patent/US20180042842A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0111597A 2001-02-14 2001-05-11 Pharmaceutical compositions comprising the cannabinoids THC and CBD Withdrawn GB2377633A (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0111597A GB2377633A (en) 2001-05-11 2001-05-11 Pharmaceutical compositions comprising the cannabinoids THC and CBD
AU2002231970A AU2002231970B2 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
MXPA03007215A MXPA03007215A (en) 2001-02-14 2002-02-14 Pharmaceutical formulations.
HU0303182A HU227452B1 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulation
GB0319041A GB2388543A (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
DK02712063.3T DK1361864T3 (en) 2001-02-14 2002-02-14 FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
EP10180638A EP2298283A3 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations comprising cannabinoids
EP10180665.1A EP2298284A3 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
CA2533400A CA2533400C (en) 2001-02-14 2002-02-14 Cannabinoids pharmaceutical formulations
PT2712063T PT1361864E (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
CZ2003-2458A CZ306277B6 (en) 2001-02-14 2002-02-14 Pump-action spray formulation
CN02808220.6A CN1886117B (en) 2001-02-14 2002-02-14 Pharmaceutical compositions
EP10180611.5A EP2286793A3 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations comprising cannabidiol
EP02712063.3A EP1361864B9 (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
US10/468,041 US10004684B2 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
KR1020037010780A KR100886668B1 (en) 2001-02-14 2002-02-14 Pharmaceutical preparations
GB0203527A GB2380129B (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
EP10180628.9A EP2292211A3 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
ES02712063.3T ES2444641T3 (en) 2001-02-14 2002-02-14 Liquid spray formulations for cannabinoid oral release
CA002438097A CA2438097C (en) 2001-02-14 2002-02-14 Cannabinoids pharmaceutical formulations
PCT/GB2002/000620 WO2002064109A2 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
IL15713002A IL157130A0 (en) 2001-02-14 2002-02-14 A cannabis based pharmaceutical formulation
NZ527289A NZ527289A (en) 2001-02-14 2002-02-14 Lipophilic medicaments and their administration via mucosal surfaces
DE10296335T DE10296335T5 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
JP2002563905A JP4467883B2 (en) 2001-02-14 2002-02-14 Pharmaceutical formulation
SI200231042T SI1361864T1 (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
PL364177A PL216740B1 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
HK03108883.0A HK1056509B (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
TW91102626A TWI222882B (en) 2001-02-14 2002-02-15 Pharmaceutical formulations
ZA2003/06074A ZA200306074B (en) 2001-02-14 2003-08-06 Mucoadhesive pharmaceutical formulations
NO20033556A NO334743B1 (en) 2001-02-14 2003-08-11 Pump-acting liquid spray formulation
CY20141100157T CY1115072T1 (en) 2001-02-14 2014-02-26 LIQUID COMPOSITIONS SPRAY FOR SUPPLY OF CANNIVOIDES THROUGH PARTY
US15/586,478 US20180042842A1 (en) 2001-02-14 2017-05-04 Pharmaceutical formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0111597A GB2377633A (en) 2001-05-11 2001-05-11 Pharmaceutical compositions comprising the cannabinoids THC and CBD

Publications (2)

Publication Number Publication Date
GB0111597D0 true GB0111597D0 (en) 2001-07-04
GB2377633A GB2377633A (en) 2003-01-22

Family

ID=9914494

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0111597A Withdrawn GB2377633A (en) 2001-02-14 2001-05-11 Pharmaceutical compositions comprising the cannabinoids THC and CBD

Country Status (1)

Country Link
GB (1) GB2377633A (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2381194A (en) * 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
US10004684B2 (en) 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
GB2377218A (en) 2001-05-04 2003-01-08 Gw Pharmaceuticals Ltd Process and apparatus for extraction of active substances and enriched extracts from natural products
GB2400320B (en) * 2001-05-04 2005-06-08 Gw Pharma Ltd Cannabinoid-rich extracts
CA2994322A1 (en) * 2002-08-14 2004-02-14 Gw Pharma Limited Botanical drug substances comprising various proportions of thc and cbd
GB2393182B (en) * 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
GB2394894B (en) * 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
US7968594B2 (en) 2005-04-27 2011-06-28 Gw Pharma Limited Pharmaceutical compositions for the treatment of pain
GB2432312A (en) * 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
GB2448535A (en) * 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
WO2008144475A1 (en) * 2007-05-17 2008-11-27 California Pacific Medical Center Methods and compositions for treating cancer
GB2450741A (en) * 2007-07-05 2009-01-07 Gw Pharma Ltd Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease
GB2450753B (en) * 2007-07-06 2012-07-18 Gw Pharma Ltd New Pharmaceutical formulation
EP2280687B1 (en) 2008-03-26 2019-02-27 Stichting Sanammad Chewing gum compositions comprising cannabinoids
GB2491118B (en) * 2011-05-20 2015-12-30 Otsuka Pharma Co Ltd Cannabinoids for use in the treatment of neuropathic pain
GB201111261D0 (en) 2011-07-01 2011-08-17 Gw Pharma Ltd Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
LT3062606T (en) 2013-10-29 2019-07-10 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
ES2787699T3 (en) * 2014-12-19 2020-10-16 Thc Pharm Gmbh The Health Concept Drink containing CBD
EP3067058A1 (en) 2015-03-13 2016-09-14 Farmagens Health Care Srl Biological composition based on engineered lactobacillus paracasei subsp. paracasei f19 for the biosynthesis of cannabinoids
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
JP6983868B2 (en) 2016-04-22 2021-12-17 レセプター・ホールディングス・インコーポレイテッド Fast-acting plant-derived pharmaceutical compounds and nutritional supplements
JP2019524655A (en) 2016-06-29 2019-09-05 キャンサイエンス イノベーションズ インコーポレーテッドＣａｎｎｓｃｉｅｎｃｅ Ｉｎｎｏｖａｔｉｏｎｓ Ｉｎｃ． Decarbonized cannabis resin, its use, and process for producing it
EA201892396A1 (en) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. QUICKLY PRODUCTIVE PLANT MEDICINES AND BIOLOGICALLY ACTIVE ADDITIVES
US20200101034A1 (en) * 2017-03-23 2020-04-02 Receptor Holdings, Inc. Rapid and controlled delivery of compositions with restored entourage effects
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
WO2019126872A1 (en) * 2017-12-27 2019-07-04 CannScience Innovations Inc. Sublingual formulations comprising cannabis resin, methods for making same and uses thereof
US20190240148A1 (en) * 2018-02-07 2019-08-08 Tarukino Holdings, Inc. Lubricant composition and method for preparing the composition
GB201806953D0 (en) 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
WO2019211793A1 (en) * 2018-05-03 2019-11-07 Radient Technologies Inc. Preparing a blend that mimics a plant profile
AU2019385420A1 (en) 2018-11-19 2021-07-08 Spoke Sciences, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
NL2022614B1 (en) 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical, phyto-cannabinoid based compositions
NL2022615B1 (en) 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
CA3158289A1 (en) * 2019-11-12 2021-05-20 Mahmoud Mohamed Abdrabo MOUSTAFA Chewing gum containing synergistic medicinal compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111377A1 (en) * 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
JP4467883B2 (en) * 2001-02-14 2010-05-26 ジーダブリュー・ファーマ・リミテッド Pharmaceutical formulation
CH695661A5 (en) * 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmaceutical composition.

Also Published As

Publication number Publication date
GB2377633A (en) 2003-01-22

Similar Documents

Publication Publication Date Title
GB0111597D0 (en) Pharmaceutical compositions
EP1450824A4 (en) Pharmaceutical composition
EP1407785A4 (en) Medicinal compositions
GB2358582B (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0009584D0 (en) Pharmaceutical compositions
GB0117057D0 (en) Pharmaceutical composition
AU8576801A (en) Pharmaceutical compositions
GB0129117D0 (en) Pharmaceutical composition
EP1408896A4 (en) Pharmaceutical composition
AU1390002A (en) Pharmaceutical compositions
GB0008485D0 (en) Pharmaceutical compositions
GB0104752D0 (en) Pharmaceutical compositions
GB0116107D0 (en) Pharmaceutical composition
GB0009613D0 (en) Pharmaceutical compositions
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (en) Pharmaceutical composition
GB2382302B (en) Pharmaceutical compositions
IL157411A0 (en) Pharmaceutical composition
GB0126732D0 (en) Pharmaceutical compositions
GB0125061D0 (en) Pharmaceutical composition
HU0103049D0 (en) Pharmaceutical composition
GB0101744D0 (en) Pharmaceutical compositions
GB0121826D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)